Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

The IL-33-PIN1-IRAK-M axis is critical for type 2 immunity in IL-33-induced allergic airway inflammation.

Nechama M, Kwon J, Wei S, Kyi AT, Welner RS, Ben-Dov IZ, Arredouani MS, Asara JM, Chen CH, Tsai CY, Nelson KF, Kobayashi KS, Israel E, Zhou XZ, Nicholson LK, Lu KP.

Nat Commun. 2018 Apr 23;9(1):1603. doi: 10.1038/s41467-018-03886-6.

2.

Loss of Tff1 Promotes Pro-Inflammatory Phenotype with Increase in the Levels of RORγt+ T Lymphocytes and Il-17 in Mouse Gastric Neoplasia.

Soutto M, Saleh M, Arredouani MS, Piazuelo B, Belkhiri A, El-Rifai W.

J Cancer. 2017 Jul 22;8(13):2424-2435. doi: 10.7150/jca.19639. eCollection 2017.

3.

An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasets.

Hill KE, Kelly AD, Kuijjer ML, Barry W, Rattani A, Garbutt CC, Kissick H, Janeway K, Perez-Atayde A, Goldsmith J, Gebhardt MC, Arredouani MS, Cote G, Hornicek F, Choy E, Duan Z, Quackenbush J, Haibe-Kains B, Spentzos D.

J Hematol Oncol. 2017 May 15;10(1):107. doi: 10.1186/s13045-017-0465-4.

4.

Variants of the ADRB2 Gene in COPD: Systematic Review and Meta-Analyses of Disease Risk and Treatment Response.

Nielsen AO, Jensen CS, Arredouani MS, Dahl R, Dahl M.

COPD. 2017 Aug;14(4):451-460. doi: 10.1080/15412555.2017.1320370. Epub 2017 May 16. Review.

PMID:
28506092
5.

Gleason Score 7 Prostate Cancers Emerge through Branched Evolution of Clonal Gleason Pattern 3 and 4.

Sowalsky AG, Kissick HT, Gerrin SJ, Schaefer RJ, Xia Z, Russo JW, Arredouani MS, Bubley GJ, Sanda MG, Li W, Ye H, Balk SP.

Clin Cancer Res. 2017 Jul 15;23(14):3823-3833. doi: 10.1158/1078-0432.CCR-16-2414. Epub 2017 Jan 24.

6.

The transcription factor ERG increases expression of neurotransmitter receptors on prostate cancer cells.

Kissick HT, On ST, Dunn LK, Sanda MG, Asara JM, Pellegrini KL, Noel JK, Arredouani MS.

BMC Cancer. 2015 Aug 27;15:604. doi: 10.1186/s12885-015-1612-3.

7.

New insights into androgenic immune regulation.

Arredouani MS.

Oncoimmunology. 2014 Dec 13;3(9):e954968. eCollection 2014 Oct.

8.

Is the scavenger receptor MARCO a new immune checkpoint?

Arredouani MS.

Oncoimmunology. 2014 Dec 15;3(10):e955709. eCollection 2014 Nov.

9.

NAD+ protects against EAE by regulating CD4+ T-cell differentiation.

Tullius SG, Biefer HR, Li S, Trachtenberg AJ, Edtinger K, Quante M, Krenzien F, Uehara H, Yang X, Kissick HT, Kuo WP, Ghiran I, de la Fuente MA, Arredouani MS, Camacho V, Tigges JC, Toxavidis V, El Fatimy R, Smith BD, Vasudevan A, ElKhal A.

Nat Commun. 2014 Oct 7;5:5101. doi: 10.1038/ncomms6101.

10.

The scavenger receptor MARCO modulates TLR-induced responses in dendritic cells.

Kissick HT, Dunn LK, Ghosh S, Nechama M, Kobzik L, Arredouani MS.

PLoS One. 2014 Aug 4;9(8):e104148. doi: 10.1371/journal.pone.0104148. eCollection 2014.

11.

Androgens alter T-cell immunity by inhibiting T-helper 1 differentiation.

Kissick HT, Sanda MG, Dunn LK, Pellegrini KL, On ST, Noel JK, Arredouani MS.

Proc Natl Acad Sci U S A. 2014 Jul 8;111(27):9887-92. doi: 10.1073/pnas.1402468111. Epub 2014 Jun 23.

12.

Immunization with a peptide containing MHC class I and II epitopes derived from the tumor antigen SIM2 induces an effective CD4 and CD8 T-cell response.

Kissick HT, Sanda MG, Dunn LK, Arredouani MS.

PLoS One. 2014 Apr 1;9(4):e93231. doi: 10.1371/journal.pone.0093231. eCollection 2014.

13.

Analysis of host gene expression changes reveals distinct roles for the cytoplasmic domain of the Epstein-Barr virus receptor/CD21 in B-cell maturation, activation, and initiation of virus infection.

Arredouani MS, Bhasin MK, Sage DR, Dunn LK, Gill MB, Agnani D, Libermann TA, Fingeroth JD.

J Virol. 2014 May;88(10):5559-77. doi: 10.1128/JVI.03099-13. Epub 2014 Mar 5.

14.

Development of a peptide-based vaccine targeting TMPRSS2:ERG fusion-positive prostate cancer.

Kissick HT, Sanda MG, Dunn LK, Arredouani MS.

Cancer Immunol Immunother. 2013 Dec;62(12):1831-40. doi: 10.1007/s00262-013-1482-y. Epub 2013 Oct 23.

15.

The role of the transcription factor SIM2 in prostate cancer.

Lu B, Asara JM, Sanda MG, Arredouani MS.

PLoS One. 2011;6(12):e28837. doi: 10.1371/journal.pone.0028837. Epub 2011 Dec 9.

16.

Defective NKT cell activation by CD1d+ TRAMP prostate tumor cells is corrected by interleukin-12 with α-galactosylceramide.

Nowak M, Arredouani MS, Tun-Kyi A, Schmidt-Wolf I, Sanda MG, Balk SP, Exley MA.

PLoS One. 2010 Jun 25;5(6):e11311. doi: 10.1371/journal.pone.0011311.

17.

Androgen ablation augments human HLA2.1-restricted T cell responses to PSA self-antigen in transgenic mice.

Arredouani MS, Tseng-Rogenski SS, Hollenbeck BK, Escara-Wilke J, Leander KR, Defeo-Jones D, Hwang C, Sanda MG.

Prostate. 2010 Jun 15;70(9):1002-11. doi: 10.1002/pros.21134.

18.

A safety-modified SV40 Tag developed for human cancer immunotherapy.

Tseng-Rogenski SS, Arredouani MS, Escara-Wilke JF, Neeley YC, Imperiale MJ, Sanda MG.

Drug Des Devel Ther. 2009 Feb 6;2:17-24.

19.

Haptoglobin deficiency facilitates the development of autoimmune inflammation.

Galicia G, Maes W, Verbinnen B, Kasran A, Bullens D, Arredouani M, Ceuppens JL.

Eur J Immunol. 2009 Dec;39(12):3404-12. doi: 10.1002/eji.200939291.

20.

Identification of the transcription factor single-minded homologue 2 as a potential biomarker and immunotherapy target in prostate cancer.

Arredouani MS, Lu B, Bhasin M, Eljanne M, Yue W, Mosquera JM, Bubley GJ, Li V, Rubin MA, Libermann TA, Sanda MG.

Clin Cancer Res. 2009 Sep 15;15(18):5794-802. doi: 10.1158/1078-0432.CCR-09-0911. Epub 2009 Sep 8.

21.

The immune boundaries for stem cell based therapies: problems and prospective solutions.

Hmadcha A, Domínguez-Bendala J, Wakeman J, Arredouani M, Soria B.

J Cell Mol Med. 2009 Aug;13(8A):1464-75. doi: 10.1111/j.1582-4934.2009.00837.x. Epub 2009 Jul 6. Review. Erratum in: J Cell Mol Med. 2009 Aug;13(8B):2754. Abdelkrim, Hmadcha [corrected to Hmadcha, Abdelkrim]; Juan, Domínguez-Bendala [corrected to Domínguez-Bendala, Juan]; Jane, Wakeman [corrected to Wakeman, Jane]; Mohamed, Arredouani [corrected to Arredouani, Mohamed]; Bernat, Soria [corrected to Soria, B.

22.

Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.

Haram KM, Peltier HJ, Lu B, Bhasin M, Otu HH, Choy B, Regan M, Libermann TA, Latham GJ, Sanda MG, Arredouani MS.

Prostate. 2008 Oct 1;68(14):1517-30. doi: 10.1002/pros.20803.

PMID:
18668517
23.

Partially circumventing peripheral tolerance for oncogene-specific prostate cancer immunotherapy.

Neeley YC, Arredouani MS, Hollenbeck B, Eng MH, Rubin MA, Sanda MG.

Prostate. 2008 May 15;68(7):715-27. doi: 10.1002/pros.20689.

24.

Fas-mediated T cell deletion potentiates tumor antigen-specific tolerance in a mouse model of prostate cancer.

Tseng-Rogenski SS, Arredouani MS, Neeley YC, Lu B, Chinnaiyan AM, Sanda MG.

Cancer Immunol Immunother. 2008 Sep;57(9):1357-65. doi: 10.1007/s00262-008-0471-z. Epub 2008 Feb 12.

PMID:
18265979
25.

Scavenger receptor class-A is a novel cell surface receptor for double-stranded RNA.

Limmon GV, Arredouani M, McCann KL, Corn Minor RA, Kobzik L, Imani F.

FASEB J. 2008 Jan;22(1):159-67. Epub 2007 Aug 20.

PMID:
17709607
26.

Maternal allergic contact dermatitis causes increased asthma risk in offspring.

Lim RH, Arredouani MS, Fedulov A, Kobzik L, Hubeau C.

Respir Res. 2007 Jul 27;8:56.

27.

Scavenger Receptors SR-AI/II and MARCO limit pulmonary dendritic cell migration and allergic airway inflammation.

Arredouani MS, Franco F, Imrich A, Fedulov A, Lu X, Perkins D, Soininen R, Tryggvason K, Shapiro SD, Kobzik L.

J Immunol. 2007 May 1;178(9):5912-20.

28.

Protection against inhaled oxidants through scavenging of oxidized lipids by macrophage receptors MARCO and SR-AI/II.

Dahl M, Bauer AK, Arredouani M, Soininen R, Tryggvason K, Kleeberger SR, Kobzik L.

J Clin Invest. 2007 Mar;117(3):757-64.

29.

Role of scavenger receptor MARCO in macrophage responses to CpG oligodeoxynucleotides.

Józefowski S, Sulahian TH, Arredouani M, Kobzik L.

J Leukoc Biol. 2006 Oct;80(4):870-9. Epub 2006 Aug 1.

PMID:
16882874
30.

The macrophage scavenger receptor SR-AI/II and lung defense against pneumococci and particles.

Arredouani MS, Yang Z, Imrich A, Ning Y, Qin G, Kobzik L.

Am J Respir Cell Mol Biol. 2006 Oct;35(4):474-8. Epub 2006 May 4.

31.

Disparate regulation and function of the class A scavenger receptors SR-AI/II and MARCO.

Józefowski S, Arredouani M, Sulahian T, Kobzik L.

J Immunol. 2005 Dec 15;175(12):8032-41.

32.

MARCO is the major binding receptor for unopsonized particles and bacteria on human alveolar macrophages.

Arredouani MS, Palecanda A, Koziel H, Huang YC, Imrich A, Sulahian TH, Ning YY, Yang Z, Pikkarainen T, Sankala M, Vargas SO, Takeya M, Tryggvason K, Kobzik L.

J Immunol. 2005 Nov 1;175(9):6058-64.

33.

Uptake and presentation of malignant glioma tumor cell lysates by monocyte-derived dendritic cells.

De Vleeschouwer S, Arredouani M, Adé M, Cadot P, Vermassen E, Ceuppens JL, Van Gool SW.

Cancer Immunol Immunother. 2005 Apr;54(4):372-82. Epub 2004 Oct 19.

PMID:
15692847
34.

Haptoglobin dampens endotoxin-induced inflammatory effects both in vitro and in vivo.

Arredouani MS, Kasran A, Vanoirbeek JA, Berger FG, Baumann H, Ceuppens JL.

Immunology. 2005 Feb;114(2):263-71.

35.

The structure and function of marco, a macrophage class a scavenger receptor.

Arredouani MS, Kobzik L.

Cell Mol Biol (Noisy-le-grand). 2004;50 Online Pub:OL657-65. Review.

PMID:
15588554
36.

The scavenger receptor MARCO is required for lung defense against pneumococcal pneumonia and inhaled particles.

Arredouani M, Yang Z, Ning Y, Qin G, Soininen R, Tryggvason K, Kobzik L.

J Exp Med. 2004 Jul 19;200(2):267-72.

37.

Haptoglobin directly affects T cells and suppresses T helper cell type 2 cytokine release.

Arredouani M, Matthijs P, Van Hoeyveld E, Kasran A, Baumann H, Ceuppens JL, Stevens E.

Immunology. 2003 Feb;108(2):144-51.

38.

Haptoglobin interacts with the human mast cell line HMC-1 and inhibits its spontaneous proliferation.

El-Ghmati SM, Arredouani M, Van Hoeyveld EM, Ceuppens JL, Stevens EA.

Scand J Immunol. 2002 Apr;55(4):352-8.

39.

Haptoglobin and the Th1/Th2 balance: hints from in vitro and in vivo studies.

Arredouani M, Matthys P, Kasran A, Baumann H, Ceuppen JL.

Redox Rep. 2001;6(6):369-71.

PMID:
11865978
40.

[Expression of the human apolipoprotein A-I gene transferred in vitro into mammalian cells and in vivo into rat liver].

Perevozchikov AP, Dizhe EB, Serov SM, Kuryshev VIu, Arredouani M, Parfenova NS, Shavlovskiĭ MM, Nasonkin IO, Drapchinskaia NL, Bondarev IE, Tsarapkina EV, Sukonina VE, Denisenko AD, Gaĭtskhoki VS, Klimov AN.

Mol Biol (Mosk). 1997 Mar-Apr;31(2):216-23. Russian. No abstract available.

PMID:
9213748
41.

[Directed transfer of the human apolipoprotein A-I gene and bacterial genes-markers into rat liver].

Perevozchikov AP, Kuryshev VIu, Arredouani M, Parfenova NS, Shavlovskiĭ MM, Sukonina VE, Dizhe EB, Orlov SV, Denisenko AD, Gaĭtskhoki VS, Klimov AN.

Dokl Akad Nauk. 1997 Feb;352(4):571-4. Russian. No abstract available.

PMID:
9213492

Supplemental Content

Loading ...
Support Center